Upregulation of CSPG4 in malignant tumors is putatively linked to their ability to bypass inherent regulatory mechanisms by suppressing apoptotic signaling, proliferating at an elevated rate and acquiring anchorage independence. The gene discussed is CSPG4; the disease is cancer.